DR.NUELL VANISHING BB- glycerin, adenosine cream 
Apharm Co., Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

arbutin, adenosine, ethylhexyl methoxycinnamate, titanium dioxide

brightening

wrinkle improvement

UV protection

Keep out of reach of children

use BB cream alone, or take the appropriate amount and apply it evenly along with the skin texture in the last stage of skin care

1) if there is any abnormal symptom or side effect, such as red spot, swelling and itching when using cosmetlcs or after using due to direct sunlight, consult dermatologists
2) Do not use for wounded areas
3) Precautions for storage and handling
keep out of reach of children, store away from direct sunlight
4) avoid the eye area

water, cyclopentasiloxane, dimethicone, etc.

For external use only

label

DR.NUELL VANISHING BB 
glycerin, adenosine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73430-0007
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN7 g  in 100 mL
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
PROPANEDIOL (UNII: 5965N8W85T)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73430-0007-130 mL in 1 TUBE; Type 0: Not a Combination Product11/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34711/01/2019
Labeler - Apharm Co., Ltd. (689054266)
Registrant - Apharm Co., Ltd. (689054266)
Establishment
NameAddressID/FEIBusiness Operations
APHARM Co., Ltd.689054266manufacture(73430-0007)

Revised: 11/2019
Document Id: 970b0ada-66bf-74fc-e053-2a95a90aee83
Set id: 970b09b1-7808-435c-e053-2a95a90a9b3c
Version: 1
Effective Time: 20191110
 
Apharm Co., Ltd.